Impact of patient selection on outcomes of PDA in very low birth weight infants

Early Human Development

Volumn 89, Issue 3, 2013, Pages 175-179

  Youn, YoungAh ^a   Lee, Ju Young ^a   Lee, Jung Hyun ^b   Kim, So Young ^c   Sung, In Kyung ^a   Lee, Jae Young ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Acute renal failure; Hemodynamically significant; Oral ibuprofen; Surgical ligation

Indexed keywords

IBUPROFEN;

ACUTE KIDNEY FAILURE; ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; ENCEPHALOMALACIA; FEMALE; GESTATIONAL AGE; HEART SURGERY; HEMODYNAMICALLY SIGNIFICANT DUCTUS ARTERIOSUS; HOSPITAL ADMISSION; HOSPITALIZATION COST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MECHANICAL VENTILATOR; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; OXYGEN CONSUMPTION; PATENT DUCTUS ARTERIOSUS; PATIENT SELECTION; RETROLENTAL FIBROPLASIA; SEPSIS; SHUNTING; VERY LOW BIRTH WEIGHT;

ADMINISTRATION, ORAL; BIRTH WEIGHT; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LIGATION; LOGISTIC MODELS; MALE; PATIENT SELECTION; REPUBLIC OF KOREA; TREATMENT OUTCOME;

EID: 84873712854     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2012.09.015     Document Type: Article

References (24)

1. Kabra N.S., Schmidt B., Roberts R.S., Doyle L.W., Papile L., Fanaroff A. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007, 150(3):229-234. [234 e1].
2. Chorne N., Leonard C., Piecuch R., Clyman R.I. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. J Pediatr 2007, 119:1165-1174.
3. Clyman R., Cassady G., Kirklin J.K., Collins M., Philips J.B. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 2009, 154:873-876.
4. Vida V.L., Lago P., Salvatori S., Boccuzzo G., Padalino M.A., Milanesi O., et al. Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants. Ann Throrac Surg 2009, 87(5):1509-1516.
5. Jhaveri N., Moon-Grady A., Clyman R.I. Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr 2010, 157:381-387.
6. Cotton R.B., Stahlman M.T., Berder H.W., Graham T.P., Catterton W.Z., Kover I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978, 93:647-651.
7. Teixeria L.S., McNamara P.J. Enhanced intensive care for the neonatal ductus arteriosus. Acta Paediatr 2006, 95:394-403.
8. Knight D.B., Laughon M.M. Evidence for active closure of patent ductus arteriosus in very preterm infants. J Pediatr 2008, 152(3):446-447. [author reply 447-448].
9. Noori S. Patent ductus arteriosus in the preterm infant: to treat or not to treat?. J Perinatol 2010, 30:S31-S37.
10. Shimada S., Kasai T., Hoshi A., Murata A., Chida S. Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome. Pediatr Int 2003, 45:255-262.
11. Meyers R.L., Alpan G., Lin E., Clyman R.I. Patent ductus arteriosus, indomethacin, and intestinal distension: effects on intestinal blood flow and oxygen consumption. Pediatr Res 1991, 29:569-574.
12. McNamara P.J., Sehgal Arvind Towards rational management of the patent ductus arteriosus; the need for disease staging. Arch Dis Child Fetal Neonatal Ed 2007, 92:F424-F427.
13. Mosca F., Bray M., Lattanzio M., Fumagalli M., Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997, 131(4):549-554.
14. Aranda J.V., Thomas R. Systematic review: intravenous ibuprofen in preterm newborns. Semin Perinatol 2006, 30(3):114-120.
15. Koehne P.S., Bein G., Alexi-Meskhishvili V., Weng Y., Bührer C., Obladen M. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med 2001, 29:327-334.
16. Jhaveri N., Soll R.F., Clyman R.I. Feeding practices and patent ductus arteriosus ligation preferences - are they related?. Am J Perinatol 2010, 27(8):667-674.
17. Clyman R., Narayanan M. Patent ductus arteriosus: a physiologic basis for current treatment practices. Current Topics in Neonatology 2000, 71-91. WB Saunders, Philadelphia.
18. Clyman R.I. Mechanisms regulating the ductus arteriosus. Biol Neonate 2006, 89:330-335.
19. Kääpä P., Lanning P., Koivisto M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand 1983, 72:179-184.
20. Shimada S., Kasai T., Konishi M., Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr 1994, 125:270-277.
21. McCurnin D., Clyman R.I. Effects of a patent ductus arteriosus on postprandial mesenteric perfusion in premature baboons. J Pediatr 2008, 122(6):e1262-e1267.
22. Pietz J., Achanti B., Lilien L., Stepka E.C., Mehta S.K. Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience. Pediatrics 2007, 119(1):e164-e170.
23. Hammerman C., Strates E., Valaitis S. The silent ductus: its precursors and its aftermath. Pediatr Cardiol 1986, 7(3):121-127.
24. Gonzalez A., Sosenko I.R., Chandar J., Hummler H., Claure N., Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000grams or less. J Pediatr 1996, 128(4):470-478.